These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 21499838

  • 1. Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation.
    Wu H, Lu W, Mahato RI.
    Pharm Res; 2011 Sep; 28(9):2098-109. PubMed ID: 21499838
    [Abstract] [Full Text] [Related]

  • 2. Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation.
    Panakanti R, Mahato RI.
    Pharm Res; 2009 Mar; 26(3):587-96. PubMed ID: 19002565
    [Abstract] [Full Text] [Related]

  • 3. Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation.
    Mundra V, Wu H, Mahato RI.
    PLoS One; 2013 Mar; 8(10):e77591. PubMed ID: 24204883
    [Abstract] [Full Text] [Related]

  • 4. RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation.
    Wu H, Yoon AR, Li F, Yun CO, Mahato RI.
    J Gene Med; 2011 Dec; 13(12):658-69. PubMed ID: 22095898
    [Abstract] [Full Text] [Related]

  • 5. Gene expression and silencing for improved islet transplantation.
    Mahato RI.
    J Control Release; 2009 Dec 16; 140(3):262-7. PubMed ID: 19376168
    [Abstract] [Full Text] [Related]

  • 6. Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human islets.
    Panakanti R, Mahato RI.
    Mol Pharm; 2009 Dec 16; 6(1):274-84. PubMed ID: 19067524
    [Abstract] [Full Text] [Related]

  • 7. Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function.
    Narang AS, Sabek O, Gaber AO, Mahato RI.
    Pharm Res; 2006 Sep 16; 23(9):1970-82. PubMed ID: 16906455
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets.
    Fiaschi-Taesch NM, Berman DM, Sicari BM, Takane KK, Garcia-Ocaña A, Ricordi C, Kenyon NS, Stewart AF.
    Diabetes; 2008 Oct 16; 57(10):2745-54. PubMed ID: 18820214
    [Abstract] [Full Text] [Related]

  • 9. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death.
    Garcia-Ocana A, Takane KK, Reddy VT, Lopez-Talavera JC, Vasavada RC, Stewart AF.
    J Biol Chem; 2003 Jan 03; 278(1):343-51. PubMed ID: 12403787
    [Abstract] [Full Text] [Related]

  • 10. Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice.
    Kerby A, Jones ES, Jones PM, King AJ.
    Cytotherapy; 2013 Feb 03; 15(2):192-200. PubMed ID: 23321331
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function.
    Ito T, Itakura S, Todorov I, Rawson J, Asari S, Shintaku J, Nair I, Ferreri K, Kandeel F, Mullen Y.
    Transplantation; 2010 Jun 27; 89(12):1438-45. PubMed ID: 20568673
    [Abstract] [Full Text] [Related]

  • 12. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice.
    Ohmura Y, Tanemura M, Kawaguchi N, Machida T, Tanida T, Deguchi T, Wada H, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Matsuura N, Ito T, Nagano H, Doki Y, Mori M.
    Transplantation; 2010 Dec 27; 90(12):1366-73. PubMed ID: 21076379
    [Abstract] [Full Text] [Related]

  • 13. Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model.
    Wu H, Wen D, Mahato RI.
    Mol Ther; 2013 Sep 27; 21(9):1778-86. PubMed ID: 23765442
    [Abstract] [Full Text] [Related]

  • 14. Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice.
    Rackham CL, Dhadda PK, Chagastelles PC, Simpson SJ, Dattani AA, Bowe JE, Jones PM, King AJ.
    Cytotherapy; 2013 Apr 27; 15(4):449-59. PubMed ID: 23321626
    [Abstract] [Full Text] [Related]

  • 15. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.
    Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, Zhang H, Song K, Meseck M, Bromberg J, Dong H.
    Diabetes; 2004 Apr 27; 53(4):963-70. PubMed ID: 15047611
    [Abstract] [Full Text] [Related]

  • 16. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice.
    Rao P, Roccisana J, Takane KK, Bottino R, Zhao A, Trucco M, García-Ocaña A.
    Diabetes; 2005 Jun 27; 54(6):1664-75. PubMed ID: 15919787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mesenchymal stromal cell secretory molecules improve the functional survival of human islets.
    Hong TW, Caxaria S, Daniels Gatward LF, Hussain S, Zhao M, King AJF, Rackham CL, Jones PM.
    Diabet Med; 2023 Dec 27; 40(12):e15227. PubMed ID: 37728506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.